Iran Press/ Iran news: In a press conference today (Tuesday), Alireza Biglari, the Head of the Pasteur Institute of Iran, and Vicente Vérez Bencomo, President of the Cuban Finlay Institute explained about the production of a joint corona vaccine.
"In phase 3 clinical trial, the efficacy of the vaccine was reported to be 91.2%, and this vaccine was 75% effective in preventing the transmission and infection of the COVID-19," said Vicente Vérez Bencomo.
The head of the Cuban Finlay Institute added: "The joint vaccination tests between Iran and Cuba will be completed by the end of the summer."
207/224
Read More:
Iran-Cuba COVID-19 vaccine, unique in the world: Health minister
3rd phase of Iran-Cuba COVID-19 vaccine clinical trial kicks off
